74 results
Page 3 of 4
DEFR14A
yxd6hrdjxy az5x
1 Dec 10
Revised proxy
12:00am
8-K
EX-99.1
l1g3miw
16 Jun 10
Other Events
12:00am
CORRESP
hf3d56h2w2g3trp42
4 Feb 10
Correspondence with SEC
12:00am
CORRESP
qgv5jxr orxuyat8
22 Jan 10
Correspondence with SEC
12:00am
8-K
EX-99.1
pj7fpvj
3 Jun 09
Dynavax Presents Additional Phase 3 Data for Heplisav(tm) Hepatitis B Vaccine at DDW Medical Conference
12:00am
8-K
EX-99.1
2xz23es
28 Apr 09
Dynavax Presents Additional Phase 3 Data for Heplisav(tm) Hepatitis B Vaccine at Easl Medical Conference
12:00am
8-K
EX-99.2
nupdg7z8fgh6ijinbzh
6 Aug 08
Dynavax Announces Second Quarter 2008 Financial Results
12:00am
8-K
EX-99.1
36zjj2v7
7 Nov 07
DYNAVAX and MERCK & CO., INC. ANNOUNCE PARTNERSHIP TO DEVELOP HEPLISAV™, AN INVESTIGATIONAL HEPATITIS B VACCINE CURRENTLY IN PHASE 3
12:00am
8-K
EX-99.1
ve36j3fuf530mkl4ye
7 Dec 06
Other Events
12:00am